Navigation Links
Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study

the PolyHeme group, and all patients who did not receive any PolyHeme were analyzed in the control group. Although the AT population was pre-specified for safety rather than efficacy, it provides a meaningful opportunity to assess mortality as well.

PP Population

The PP population is comprised of the 586 patients both appropriately randomized and correctly treated. The PP population does not include 128 patients who had major protocol violations related to eligibility or treatment regimen. Since the PP patients were treated exactly as specified in the protocol, Northfield believes the PP population represents the clearest opportunity to assess a treatment effect.

In the primary MITT population, the upper limit of the confidence interval was 7.65%. In the AT population, the upper limit was 7.06%. In the PP population, the upper limit was 6.29%. The data are shown in Table 1. -0-



                               TABLE 1

                           DAY 30 MORTALITY



                           PolyHeme         Control        Upper Limit

                          (deaths/N)   %   (deaths/N)  %

------------------------- ---------- ----- ---------- ---- -----------

MITT                       47/350    13.4   35/364    9.6     7.65%

------------------------- ---------- ----- ---------- ---- -----------

AT                         46/349    13.2   36/365    9.9     7.06%

------------------------- ---------- ----- ---------- ---- -----------

PP                         31/279    11.1   28/307    9.1     6.29%

------------------------- ---------- ----- ---------- ---- -----------

Secondary efficacy endpoints of the study included Day 1 mortality (Table 2), the incidence of multiple organ failure, the use of donated blood through Day 1, and an analysis of mortality by the mechanism of injury (blunt versus penetrating trauma). The incidence of transfusion of donated blood was significantly lower in the PolyHeme group at 41% than
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Northfield Laboratories Investor Update
2. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
3. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study for Milnacipran as a Treatment for Fibromyalgia Syndrome
4. Columbia Laboratories Reports Preliminary Findings from the Ongoing Data Analysis of the Phase III Clinical Study of PROCHIEVE 8% (progesterone gel) to Prevent Preterm Birth
5. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
6. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
7. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
8. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
9. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
10. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
11. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
Post Your Comments:
(Date:1/23/2015)... 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is ... Advaxis, Inc. ("Advaxis" or the "Company") (NASDAQ: ... fiduciary duties to shareholders. On January 21, ... reporting that Advaxis had misrepresented the clinical data for ...
(Date:1/23/2015)... , Jan. 23, 2015  Now available for sale, ... 7,849,611) support that prevents ankle sprains by cushioning the ... it fits securely around the outside of any shoe ... & comfort while still offering protection against sprains. With ...
(Date:1/23/2015)... , Jan. 23, 2015 Cord Blood America, Inc. ( ... or the "Company")  filed a Preliminary Proxy Statement, Schedule 14A, ... today, and provides an update for shareholders detailing why a ... requested. Dear Shareholders, As we reflect ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4
... CRDC ) today announced that it will release ... 2011, on Monday, February 6, 2012, after the markets close. ... Eastern Time to discuss the financial results and provide an ... Call Details To access the live conference ...
... & Science business of Thomson Reuters announced an ... (IPEA). This partnership provides IPEA,s Direction of Sectorial ... (DISET) branch with access to the Newport ... and tools for sourcing global pharmaceutical ingredients. ...
Cached Medicine Technology:Cardica to Announce Fiscal 2012 Second Quarter Financial Results on Monday, February 6, 2012 2Thomson Reuters Helps Brazil's Institute for Applied Economic Research Identify New Generic Drug Opportunities 2
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post ... insurance policy . , Auto insurance quotes help many ... no longer necessary to call an agent or visit an ... on a single website: http://autocarinsurancebest.com/ . , Every business ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Joan Lunden, ... keynote speaker at the upcoming 32nd Annual Miami ... Physicians’ Education Resource®, LLC (PER®) , shares that ... have gone undetected if she had not followed up ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne wedding ... revenues in the past three years. Today, the business announces ... According to the sales manager of the company, this is ... 2015. This point can be reflected on the discounted wedding ...
(Date:1/22/2015)... Payday lending practices in four southern states ... distress to the states that permit them, according to ... on Race and Wealth. , While they generate hundreds ... at the same time substantially depress economic activity, according ...
(Date:1/22/2015)... a famous dress online store for wedding dresses and other ... of wedding dresses , and launches a site-wide women’s dress ... on your big day; the wedding gown is the most ... find the most suitable wedding dress. Now, we are proud ...
Breaking Medicine News(10 mins):Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... Sets New Standard for Prescription Prenatal Vitamins , ... the most comprehensive once-daily prescription prenatal vitamin in its category, ... , ST. LOUIS, Dec. 17 KV ... branded pharmaceutical subsidiary - the U.S. market leader in ...
... Mass., Dec. 17 Biopure Corporation (Nasdaq: ... the Food and Drug Administration (FDA) an investigational new ... 2 clinical trial of the company,s oxygen therapeutic Hemopure(R) ... trial Hemopure would be studied for use ...
... Health Successfully Completed and Closed the Amendment of the ... Governing the November 2006 Notes , ------------------------------------------------- ... Dec. 17 /PRNewswire-FirstCall/ - BELLUS Health Inc. (NASDAQ: ... provided formal notice to the NASDAQ Stock Market of ...
... commit to continue progress. Broadcast video of President Sirleaf,s speech onboard the ... download with registration at www.mercyshipsnews.org or upon request. , ... ... out of the Free Port of Monrovia, Liberia, this past weekend, wrapping ...
... Marketing Pro Toby Younis today announced a free webcast entitled, "BuzzMaking: ... is designed for executives in B2B companies facing challenging revenue goals ... ... December 17, 2008-- Widely recognized B2B marketing expert Toby Younis ...
... America (PHA) is applauding President-elect Barack Obama,s selection of Senator ... and Human Services in his Cabinet. , ... South Dakota, is both known and respected by Physician Hospitals ... , "Tom Daschle is an extraordinary ...
Cached Medicine News:Health News:KV Pharmaceutical Launches Enhanced Formulation of PrimaCare ONE(R) 2Health News:KV Pharmaceutical Launches Enhanced Formulation of PrimaCare ONE(R) 3Health News:KV Pharmaceutical Launches Enhanced Formulation of PrimaCare ONE(R) 4Health News:KV Pharmaceutical Launches Enhanced Formulation of PrimaCare ONE(R) 5Health News:Biopure Submits IND Application for Proposed Clinical Trial in Patients with Acute Myeloid Leukemia 2Health News:Biopure Submits IND Application for Proposed Clinical Trial in Patients with Acute Myeloid Leukemia 3Health News:BELLUS Health announces formal notice to voluntarily delist from NASDAQ 2Health News:BELLUS Health announces formal notice to voluntarily delist from NASDAQ 3Health News:Mercy Ship Sails On From Liberia After Four-Year Rebuilding Effort 2Health News:Mercy Ship Sails On From Liberia After Four-Year Rebuilding Effort 3Health News:B2B Marketing Pro Toby Younis Announces Free Webcast on "BuzzMaking" 2Health News:Physician Hospitals of America (PHA) Applauds President-Elect Obama's Selection of Sen. Daschle as HHS Secretary 2
... average 5:1 increase in usage time at all ... standard cannula. , ,The combination of the ... patients a superior alternative to liquid oxygen. , ... , ,NOTE: Each model ...
... An All-In-One Conserver., ,Offers an average 5:1 ... ,Allows the use of a standard cannula. ... and lightweight cylinders offers ambulatory oxygen patients a ... backed by a 2-year warranty. ...
... average 5:1 increase in usage time at all ... standard cannula. , ,The combination of the ... patients a superior alternative to liquid oxygen. , ... , ,NOTE: Each model ...
... an average 5:1 increase in usage time at ... a standard cannula. , ,The combination of ... oxygen patients a superior alternative to liquid oxygen. ... , ,NOTE: Each ...
Medicine Products: